car t-cells directed against bcma in mm
Published 7 years ago • 178 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:13
car t-cells: targeting bcma
-
1:31
integrating bcma-directed bispecifics and car-t into the myeloma treatment landscape
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
3:17
anti-bcma car t-cells for mm: durable clinical responses with ide-cel (formerly bb2121)
-
6:34
bcma-cd38 bispecific car-t cells in r/r mm
-
3:35
the future of anti-bcma car t-cell therapy in myeloma
-
1:45
anti-bcma car t-cell therapy for multiple myeloma: latest studies
-
1:02
the use of car-t cell products in a real-world setting
-
4:43
immunotherapy & car t cells: part 1
-
11:18
car-t cells: engineered cancer killers
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:30
clinical manufacturing of car t-cells
-
5:12
clinical activity seen with anti-bcma car t-cell therapy for heavily pre-treated multiple myeloma
-
2:44
sequential cd19 and bcma car-t
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
1:02
bcma-specific car-t cells for r/r multiple myeloma
-
1:55
developing the next generation of car-t cells
-
3:27
car-t cells in myeloma
-
11:40
immunotherapy of myeloma: bcma/slamf7 car t-cells & bites
-
1:06
car t-cell manufacturing: the ucl group's experience
-
1:19
quality control in manufacturing car-t cell therapies